Free Trial

Pliant Therapeutics (PLRX) Insider Trading & Ownership

Pliant Therapeutics logo
$14.37 +0.65 (+4.74%)
(As of 12/17/2024 ET)

Pliant Therapeutics (NASDAQ:PLRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$1.67 M
Get PLRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pliant Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PLRX Insider Buying and Selling by Quarter

Pliant Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/10/2024Bernard CoulieCEOSell38,710$11.56$447,487.60  
7/10/2024Eric LefebvreInsiderSell12,319$11.56$142,407.64  
7/10/2024Keith Lamont CummingsCFOSell10,911$11.56$126,131.16  
7/10/2024Mike OuimetteGeneral CounselSell7,656$11.56$88,503.36  
1/17/2024Bernard CoulieCEOSell25,721$17.23$443,172.83  
1/17/2024Hans HullInsiderSell9,786$17.23$168,612.78  
1/17/2024Keith Lamont CummingsCFOSell9,781$17.23$168,526.63  
1/17/2024Mike OuimetteGeneral CounselSell5,197$17.23$89,544.31  
(Data available from 1/1/2013 forward)

PLRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Pliant Therapeutics includes Bernard Coulie, Eric Lefebvre, Hans Hull, Keith Lamont Cummings, and Mike Ouimette. Learn more on insiders at PLRX.

6.40% of Pliant Therapeutics stock is owned by insiders. Learn more on PLRX's insider holdings.

The following insiders have sold PLRX shares in the last 24 months: Bernard Coulie ($6,436,751.41), Eric Lefebvre ($3,377,967.95), Hans Hull ($429,992.78), Keith Lamont Cummings ($2,149,054.00), and Mike Ouimette ($1,528,640.55).

Insiders have sold a total of 602,109 Pliant Therapeutics shares in the last 24 months for a total of $13,922,406.69 sold.

Pliant Therapeutics Key Executives

  • Dr. Bernard Coulie M.B.A. (Age 57)
    M.D., Ph.D., President, CEO & Director
    Compensation: $996.97k
  • Dr. Keith Lamont Cummings M.B.A. (Age 47)
    M.D., Chief Financial Officer
    Compensation: $684.14k
    1 recent trades
  • Mr. Mike Ouimette J.D. (Age 51)
    General Counsel & Corporate Secretary
    Compensation: $606.03k
    1 recent trades
  • Mr. Johannes P. Hull (Age 49)
    Chief Business Officer
    Compensation: $602.51k
  • Dr. Éric Lefebvre M.D. (Age 60)
    Chief Medical Officer
    Compensation: $734.41k
  • Dr. Rik Derynck
    Scientific Founder & Member of Scientific Advisory Board
  • Mr. Dean Sheppard M.D.
    Scientific Founder & Member of Scientific Advisory Board
  • Mr. Bill DeGrado Ph.D.
    Scientific Founder & Member of Scientific Advisory Board
  • Mr. Hal Chapman M.D.
    Scientific Founder & Member of Scientific Advisory Board
  • Mr. Craig D. Muir
    Interim Chief Technology Officer


This page (NASDAQ:PLRX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners